Market Place
Sourcing Support
Prinston`s Generic Vortioxetine Receives Tentative Approval in the U.S.
28 Jul 2022 //
FDA
Alembic Pharma gets tentative USFDA approval for depressive disorder drug
07 Jan 2022 //
ECONOMIC TIMES
Alembic Pharm`s Generic Vortioxetine Receives Approval in the U.S.
05 Jan 2022 //
FDA
Vortioxetine significantly improves overall functioning in a global real-world
22 Apr 2021 //
CISION
Amneal Pharm`s Generic Vortioxetine Receives Tentative Approval In US
16 Sep 2019 //
FDA
Alkem Labs Generic Vortioxetine Receives Tentative Approval in US
24 Aug 2019 //
FDA
Lundbeck’s key products shine in Q2 but problems remain
14 Aug 2019 //
PMLIVE
DCGI approves Brintellix in India for Major Depressive Disorder
11 Oct 2018 //
ECONOMIC TIMES
DCGI approves Brintellix in India for Major Depressive Disorder
11 Oct 2018 //
ECONOMIC TIMES
Takeda files marketing application in Japan for MDD med vortioxetine
29 Sep 2018 //
SEEKING ALPHA
Takeda and Lundbeck submit NDA for vortioxetine in Japan for MDD
28 Sep 2018 //
GLOBENEWSWIRE
Trintellix (vortioxetine hydrobromide): H. Lundbeck A/S, Takeda Pharmaceutical Company Ltd. v. Apicore US LLC
16 Jul 2018 //
PATENT LITIGATION
Trintellix® (Vortioxetine HCL) : H. Lundbeck A/S v. MSN Laboratories
07 Jun 2018 //
PATENT LITIGATION
Trintellix® ( vortioxetine hydrobromide): H. Lundbeck v. Sigmapharm Lab
03 May 2018 //
PATENT LITIGATION
Trintellix® ( vortioxetine hydrobromide): H. Lundbeck v. Torrent Pharma
03 May 2018 //
PATENT LITIGATION
Trintellix (Vortioxetine): H. Lundbeck v. Sandoz
30 Jan 2018 //
PATENT LITIGATION
Trintellix (Vortioxetine): H. Lundbeck v. Hetero USA
30 Jan 2018 //
PATENT LITIGATION
Trintellix (Vortioxetine): H. Lundbeck v. Amneal Pharmaceuticals
30 Jan 2018 //
PATENT LITIGATION
Trintellix® (Vortioxetine Hcl): H. Lundbeck v. Zydus Pharmaceuticals (USA)
26 Jan 2018 //
PATENT LITIGATION
Trintellix® (Vortioxetine Hydrobromide): H. Lundbeck v. Cipla Limited
25 Jan 2018 //
PATENT LITIGATION
Trintellix® (Vortioxetine Hydrobromide): H. Lundbeck V. Zydus Pharma (USA)
25 Jan 2018 //
PATENT LITIGATION
Trintellix® (Vortioxetine Hydrobromide): H. Lundbeck V. Torrent Pharmaceuticals
25 Jan 2018 //
PATENT LITIGATION
Trintellix® (Vortioxetine Hydrobromide):H. Lundbeck V. Prinston Pharmaceutical
25 Jan 2018 //
PATENT LITIGATION
Trintellix® (Vortioxetine Hydrobromide:H. Lundbeck V. Macleods Pharmaceuticals
12 Jan 2018 //
PATENT LITIGATION
Trintellix® (Vortioxetine Hydrobromide): H. Lundbeck V. Lupin
12 Jan 2018 //
PATENT LITIGATION
Trintellix® (Vortioxetine Hydrobromide): H. Lundbeck V. Apotex Inc
12 Jan 2018 //
PATENT LITIGATION
Trintellix® (Vortioxetine Hydrobromide): H. Lundbeck V. Unichem Lab
12 Jan 2018 //
PATENT LITIGATION
Lundbeck & Takeda receive Complete Response Letter from the FDA for Trintellix
24 Jun 2017 //
GLOBENEWSWIRE
Takeda inaugurates €100m German oral solid dose plant
21 Jun 2017 //
IN PHARMATECHNOLOGIST
Lundbeck, Takeda drug fails to best placebo in ADHD PhII
02 Nov 2016 //
FIERCE BIOTECH
Trintellix (vortioxetine) Now Available in U.S. Pharmacies
01 Jun 2016 //
PR NEWSWIRE
Brintellix? Nope, Trintellix. Lundbeck, Takeda rebrand antidepressant
04 May 2016 //
FIERCE PHARMA
Lundbeck slides after FDA rejects label claim against AdComm recommendation
01 Apr 2016 //
FIERCE BIOTECH
FDA rejects Brintellix label expansion for cognitive symptoms
30 Mar 2016 //
PHARMATIMES
Takeda and Lundbeck Receive Complete Response Letter for Brintellix® (vortioxetine) sNDA
29 Mar 2016 //
PR NEWS WIRE
Lundbeck wins U.S. backing that may extend use of anti-depressant
04 Feb 2016 //
REUTERS
NICE backs new therapies for depression, melanoma
26 Nov 2015 //
PHARMATIMES
Lundbeck, Takeda file cognitive data for Brintellix with FDA
12 Aug 2015 //
PHARMA TIMES
FDA to review Takeda`s depression drug
11 Aug 2015 //
BIOSPECTRUM ASIA
FDA Warns About Mixups Between Drugs With Similar Names
31 Jul 2015 //
CONSUMERIST
